No profile data available.
Seelos Therapeutics, Inc. (SEELQ) is a healthcare company in the brain and nerve treatment drugs industry, based in New York, United States, with about 8 full-time employees.
It reported revenue of $0 for fiscal year 2023, and net income of -$37.88 million. In Q2 2024 (the quarter ended June 30, 2024) revenue was $0. Its market capitalization was $58 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 8, 2026.
, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders.
Seelos Therapeutics reported $0 in revenue for fiscal year 2023. In Q2 2024 revenue was $0.
$58 as of October 8, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Oragenics, Inc. (OGEN), Protagenic Therapeutics, Inc. (PTIX), PaxMedica, Inc. (PXMD).